SY-5102

CAT: 0804-HY-180355Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-180355Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
SY-5102 is a potent, selective and orally active cyclin-dependent kinase (CDK7) inhibitor with a Kd of 0.03 nM. SY-5102 shows anti-proliferative activity against HCC70 cells with an EC50 of 9 nM. SY-5102 can inhibit CDK7-mediated CAK function (downregulate CDK2 Thr160 phosphorylation) and TFIIH transcription function (downregulate RNA polymerase II Ser5 phosphorylation) . SY-5102 can induce G2/M cell cycle arrest, downregulate the expression of the oncogene c-Myc, and ultimately trigger cancer cell apoptosis. SY-5102 can be used for the research of triple-negative breast cancer (TNBC) [1].
CAS Number
[2365230-48-2]
UNSPSC
12352005
Target
Apoptosis; CDK; c-Myc; Ser/Thr Kinase
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
FC(F)(C1=CN=C(N[C@H]2CCCNC2)N=C1C3=CNC4=NC(C5=C(C)ON=C5C)=CC=C34)F
Molecular Formula
C22H22F3N7O
Molecular Weight
457.45
References & Citations
[1]Marineau JJ, et al. Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7. J Med Chem. 2022 Jan 27;65 (2) :1458-1480.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2; CDK7

Related Products

CatalogName
HY-138293-01SY-5609
HY-106947-01SY-640
HY-150795-01SY-LB-35
HY-150793-01SY-LB-57
HY-D1294SY-21 NHS ester
HY-B0793-01AZ-5104
HY-101181THK-5105
HY-13252-01MK-5108
HY-B0793S1AZ-5104-d2
HY-13545-01ABT-510

Alternative Products

CatalogName
BGI-5102Stability Test Chamber (BGI-5102)
MBS133151SY-1365
M28064-01SY-5609
T37859-01SY-640
T60429SY-LB-57
MBS5803093SY-LB-35
A18482-100SY-1365 100mg
12-8371-250Anti-Epstein-Barr Virus, VCA (EBV-5102)
ARC0323HS-SY-II
152134Sunset Yellow (SY)

Popular Products